Access cutting-edge idiopathic pulmonary fibrosis treatment through this phase 2 clinical trial at a research site in Orlando. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Orlando location
Preparing your pre-screening questions…
Access idiopathic pulmonary fibrosis specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related idiopathic pulmonary fibrosis treatment provided free
Check if you qualify for this idiopathic pulmonary fibrosis clinical trial in Orlando, FL
No-Cost Study Care
Local to Orlando
Convenient for FL residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The goal of this clinical trial is to learn about INS018\_055 in adults with Idiopathic Pulmonary Fibrosis (IPF). The primary objective is to evaluate the safety and tolerability of INS018\_055 orally administered for up to 12 weeks in adult subjects with IPF compared to placebo.
Sponsor: InSilico Medicine Hong Kong Limited
Yes, this clinical trial (NCT05975983) has an active research site in Orlando, FL that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for idiopathic pulmonary fibrosis treatment options in Orlando, FL, this clinical trial (NCT05975983) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Orlando research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced idiopathic pulmonary fibrosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all idiopathic pulmonary fibrosis clinical trials near you to find additional studies recruiting in your area.
See all pulmonary fibrosis clinical trials recruiting in Orlando — not just this study.
Browse Pulmonary Fibrosis Trials in Orlando →